CWM »

Mersana Therapeutics shares owned by CWM

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by CWM from 13F filings

Historical chart of CWM investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by CWM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by CWM

Quarter filed Position value Share count Share price at filing
2025-09-30 $22k 2.9k 7.64

More positions owned by CWM

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Spdr Series Trust Portfolio S&p500 (SPLG)
Apple (AAPL)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Ishares Tr S&p 500 Grwt Etf (IVW)
Microsoft Corporation (MSFT)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Spdr Series Trust Portfolio Agrgte (SPAB)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 100 Etf (OEF)
Pimco Etf Tr Active Bd Etf (BOND)
Amazon (AMZN)

View all positions for CWM

Top funds holding Mersana Therapeutics

Nextech Invest
Alamea Verwaltungs GmbH
Bain Capital Life Sciences Investors
Vanguard Group
Schonfeld Strategic Advisors
Rock Springs Capital Management
Acadian Asset Management
Silverarc Capital Management
683 Capital Management
BlackRock
Renaissance Technologies
Millennium Management
5AM Venture Management
Mackenzie Financial
AQR Capital Management

View all funds holding Mersana Therapeutics